Oxcarbazepine
NDC 62135-841, Oxcarbazepine, suspension, from Chartwell RX, LLC.
- Product NDC
- 62135-841
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212428
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-841-24 | 62135084124 | 20 CUP, UNIT-DOSE in 1 CARTON (62135-841-24) / 5 mL in 1 CUP, UNIT-DOSE (62135-841-45) |
| 62135-841-54 | 62135084154 | 250 mL in 1 BOTTLE (62135-841-54) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c2affa00-1d57-4d85-8db3-745191b4714dNADAC price for package 62135084154
GET /v1/drugs/nadac/62135084154
Use it
Look up 62135-841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.